Cite Filings / EBS / 0000093751-26-000044
Feed Companies Filings Check
Sign in
SCHEDULE 13G

Statement of Beneficial Ownership

Emergent BioSolutions Inc. · Filed 2026-02-09 · Acc 0000093751-26-000044

Documents 1

  • SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

  • 2026-04-09 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-02-10 4 SVP, General Counsel, Corp Sec gave up 918 shares (to pay taxes)
  • 2026-02-10 4 SVP, Products Business returned 8,655 shares (to the company)
  • 2026-02-10 4 EVP, Quality & Ethics, and CPL returned 28,847 shares (to the company)
  • 2026-02-10 4 EVP, Chief Financial Officer returned 46,155 shares (to the company)
  • 2026-02-09 SCHEDULE 13G Statement of Beneficial Ownership
  • 2025-07-17 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Oak Hill Advisors LP 7.5%
  2. 2026-11-16 SCHEDULE 13G/A · American Century Investment Management, Inc. 6.5%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…